Table 3

The impact of platelet transfusions on bleeding in critically ill neonates with thrombocytopenia

ReferenceNPopulationStudy designResultsStudy quality*
20 1283 VLBW neonates Prospective observational Institution with fewest PLT transfusions had least number of IVH cases. Infants with a greater incidence of IVH were more likely to have received PLT transfusions on days 1 and 3 (OR, 3.6; 95% CI, 1.5-8.3). Low 
14 194 Neonates Prospective cohort Major hemorrhage occurred in 40% of 31 transfused neonates (≥5 transfusions) vs 5% in 53 nontransfused neonates Moderate 
22 168 Neonates Prospective observational Twenty-one percent (95% CI, 8%-31%) reduction in minor bleeds during the 12 h period after PLT transfusion compared with 12 h before PLT transfusion High 
16 164 Preterm neonates Case control (94 cases, 70 controls) Overall 37/60 (61.7%) transfused neonates had IVH vs 7/22 (31.8%) nontransfused neonates (similar across gestational age groups) Low 
152 Preterm neonates RCT Major bleeding: 22/78 (28.2%) in the intervention group vs 19/74 (25.7%) in controls (PLT transfusions for platelets below 50 × 109/L); P = .73 Low 
18 61 Neonates Retrospective cohort Bleeding incidence: 60% with 1 transfusion; 42.3% with 2-4 transfusions; 35.7% with >4 transfusions Low 
17 45 Neonates Retrospective cohort Nineteen percent bleeding incidence in patients who received ≥20 PLT transfusions Low 
21 44 Preterm neonates Retrospective review No patient (25 transfused, 19 nontransfused) developed new or extended IVH Moderate 
19 NR Neonates Prospective cohort Transfusion protocol based on PLT mass (PLT count × mean PLT volume) was associated with fewer grade 3 and 4 IVHs compared with a PLT-count based transfusion protocol (1.8 vs 0.4%, P = .01) Low 
ReferenceNPopulationStudy designResultsStudy quality*
20 1283 VLBW neonates Prospective observational Institution with fewest PLT transfusions had least number of IVH cases. Infants with a greater incidence of IVH were more likely to have received PLT transfusions on days 1 and 3 (OR, 3.6; 95% CI, 1.5-8.3). Low 
14 194 Neonates Prospective cohort Major hemorrhage occurred in 40% of 31 transfused neonates (≥5 transfusions) vs 5% in 53 nontransfused neonates Moderate 
22 168 Neonates Prospective observational Twenty-one percent (95% CI, 8%-31%) reduction in minor bleeds during the 12 h period after PLT transfusion compared with 12 h before PLT transfusion High 
16 164 Preterm neonates Case control (94 cases, 70 controls) Overall 37/60 (61.7%) transfused neonates had IVH vs 7/22 (31.8%) nontransfused neonates (similar across gestational age groups) Low 
152 Preterm neonates RCT Major bleeding: 22/78 (28.2%) in the intervention group vs 19/74 (25.7%) in controls (PLT transfusions for platelets below 50 × 109/L); P = .73 Low 
18 61 Neonates Retrospective cohort Bleeding incidence: 60% with 1 transfusion; 42.3% with 2-4 transfusions; 35.7% with >4 transfusions Low 
17 45 Neonates Retrospective cohort Nineteen percent bleeding incidence in patients who received ≥20 PLT transfusions Low 
21 44 Preterm neonates Retrospective review No patient (25 transfused, 19 nontransfused) developed new or extended IVH Moderate 
19 NR Neonates Prospective cohort Transfusion protocol based on PLT mass (PLT count × mean PLT volume) was associated with fewer grade 3 and 4 IVHs compared with a PLT-count based transfusion protocol (1.8 vs 0.4%, P = .01) Low 

VLBW, very low birth weight. Other abbreviations are explained in Table 1.

*

Study quality included applicability to the research question.

or Create an Account

Close Modal
Close Modal